Leerink Partners Downgrades Humana (HUM) to Market Perform, 'Visibility into Recovery Diminished'

Piper Sandler Downgrades Humana (HUM) to Neutral

Piper Sandler analyst Jessica Tassan downgraded Humana (NYSE: HUM) from Overweight to Neutral with a price target of $274.00 (from $392.00).

The analyst comments "HUM published an 8K indicating only 1.6M, or 25%, of the company's MA/ SNP members are enrolled in plans rated 4.0+ Stars for 2025.... More

Raymond James Reiterates Market Perform Rating on Humana (HUM)

Raymond James analyst John Ransom reiterated a Market Perform rating and {REMOVEPT} price target on Humana (NYSE: HUM).

The analyst comments "HUM management hosted a call at noon today for the sell side, and the stock had a modest bounce from the initial sell-off, likely due to the not-zero chance that their appeal to CMS might succeed and that there are not zero offsets, including more TBC flexibility and the ability to migrate group MA members to a 4.5 Star plan. At the current price of $247/share (down ~$150 from the recent peak), we... More

Wells Fargo Reiterates Overweight Rating on Humana (HUM)

Wells Fargo analyst Stephen Baxter reiterated an Overweight rating and $387.00 price target on Humana (NYSE: HUM)

The analyst comments "Analysis of Plan Finder. Our review of Medicare Plan Finder suggested that contracts H5216, H5619, H6622, H0028, and H5525 were potentially at risk if filtering functionality was indicative of actual results. Of the... More

Bernstein SocGen Group Reiterates Market Perform Rating on Humana (HUM)

Bernstein SocGen Group analyst Lance Wilkes reiterated a Market Perform rating and $405.00 price target on Humana (NYSE: HUM)

The analyst comments "Yesterday HUM issued a press release outlining their MA offerings for 2025, which was marketing like in tone, presenting how attractive the plans are for... More

Barclays Takeaways from Humana (HUM) Mgmt Call

Barclays analyst Andrew Mok reiterated an Overweight rating and $364.00 price target on Humana (NYSE: HUM)

The analyst comments "Initial HUM Call Takeaways: At noon today, HUM hosted a group conference call with the sellside to take questions over the loss of its bonus star ratings. See below for our raw notes: HUM Participants Include: CEO Jim Rechtin, CFO Susan Diamond, and President of Medicare & Medicaid George Renaudin, and Vice President of IR Lisa Stoner Jim Rechtin Comments: Goes without saying -> disappointed with results Too much concentration in a specific contract (5216) -> will... More

Morgan Stanley Reiterates Equal-weight Rating on Humana (HUM)

Morgan Stanley analyst Erin Wright reiterated an Equal-weight rating and $374.00 price target on Humana (NYSE: HUM).

The analyst comments "What happened? HUM Disclosed a Meaningful Reduction in 4+ Star Plan Members (PY26) to 25% (from 94%) Driven, in part, by Largest Contract (H5216). HUM released an... More

JPMorgan on Humana (HUM): 'We believe that HUM will need to speak to the general impact of the potential reduction in stars for 2026'

JPMorgan analyst Lisa Gill reiterated a Neutral rating and $396.00 price target on Humana (NYSE: HUM).

The analyst comments "This morning, HUM announced that, based on preliminary data from CMS (we wrote about an issue with Plan Finder potentially revealing star ratings), it expected 1.6M members (or roughly 25%) currently enrolled in plans that will be in 4+ star rated plans for 2025, down from 94% in 2024. A large driver, as we wrote about yesterday, is the H5216 contract which has ~45% of HUMs MA membership and preliminary data suggests will step down to 3.5 stars in 2025 from 4.5 stars in 2024.... More

BTIG Comments on Humana (HUM)

BTIG Comments on Humana (NYSE: HUM)

The analyst comments "This morning, 10/2/24 BMO, Humana (HUM, Not Rated) filed an 8K announcing a significant expected decline in the number of members that will be enrolled in an MA plan rated 4 Stars and above for 2025. The filing comes after the stock traded down ~12% yesterday. Preliminary 2025 MA Star Ratings data provided by CMS shows that as of 10/1/24, HUM has... More

Stephens Downgrades Humana (HUM) to Equal Weight

(Updated - October 2, 2024 9:14 AM EDT)

Stephens analyst Scott Fidel downgraded Humana (NYSE: HUM) from Overweight to Equal Weight, price target $250.00 (from $400.00).

The analyst comments "HUM today released an 8-K disclosing preliminary 2025 MA STAR results (public release on 10/10/24) with only ~25% (~1.6... More

Mizuho Trade Desk Comments on 'Supernova' Blowup at Humana (HUM): 'it is very likely the financials are impaired especially into FY26'

Mizuho Trade Desk Comments on 'Supernova' Blowup at Humana (NYSE: HUM): 'it is very likely the financials are impaired especially into FY26'

The analyst comments "HUM is currently trading lower by 20% following preliminary 2025 Medicare Advantage Star Ratings data from CMS. The drop in STARS we would argue is far worse than even bearish investors believed would be the outcome as the Company is reporting only 25% of its members are enrolled in plans rated 4-stars and above, down from 95% headed into this calendar year. Though the Company is asserting it narrowly... More

Humana slumps as data shows membership in high-rating Medicare plans declined

Investing.com -- Shares in insurer Humana (NYSE: HUM) slipped in premarket US trading on Wednesday after data showed that the proportion of its membership enrolled in four-star Medicare plans and above for next year fell sharply.

Humana is a major seller of government-backed Medicare Advantage plans, which are designed for adults aged 65 and older.

Preliminary figures from the Medicare Advantage Star Ratings, a measure of the performance of health and prescription drug plans carried out by the Centers for Medicare and Medicaid Services, found that 25% of... More

Leerink on Humana (HUM): 'Broad-Based Benefit Cuts Evident within Plan Finder for 2025'

Leerink on Humana (NYSE: HUM): 'Broad-Based Benefit Cuts Evident within Plan Finder for 2025'.

The analyst comments " Bottom Line: Analyzing Plan Finder suggests broad-based benefit cuts across plans with CVS (MP, Cherny) followed by UNH (OP) and HUM (OP) making the largest. Medicare Plan Finder went live for 2025 health plans today, giving us... More

Wolfe Comments on Humana (HUM): 'The logic path that points to trouble at HUM began w/the co. being non-responsive on Stars'

Wolfe Comments Humana (NYSE: HUM): 'The logic path that points to trouble at HUM began w/the co. being non-responsive on Stars'.

The analyst comments " Several Data Points Indicate Potential HUM Pressure But One Stands Against It The logic path that points to trouble at HUM began w/the co. being non-responsive on Stars while several peers did not provide update but body language... More

Barclays on Humana (HUM): 'If Plan Finder ratings are correct, the earnings impact to HUM would be significant'

Barclays on Humana (NYSE: HUM): 'If Plan Finder ratings are correct, the earnings impact to HUM would be significant'

The analyst comments ": If Plan Finder ratings are correct, the earnings impact to HUM would be significant, which explains Tuesday's market reaction. We estimate that every... More

Humana shares tumble as 2025 membership for its top-rated Medicare plans slump

By Sriparna Roy and Bhanvi Satija

(Reuters) -Humana's shares fell as much as 22.4% on Wednesday, as the health insurer said enrollments in its top-rated Medicare insurance plans dropped sharply, casting a cloud over the company's 2026 revenue and bonus payments.

The sell-off wiped nearly $4 billion from the company's market value after it said the quality rating of one of its plans, which accounts for nearly half of its Medicare Advantage (MA) memberships, fell to 3.5 down from 4.5 last year.

Based on preliminary 2025 MA star ratings data, the... More

Humana (HUM) falls after preliminary Medicare Advantage data

Humana (HUM) falls after preliminary Medicare Advantage data.

"Based on preliminary 2025 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare and Medicaid Services (CMS), which became available in CMS Plan Finder as of October 1, 2024, Humana Inc. (the Company) has approximately 1.6 million, or 25%, of its members currently enrolled in plans rated 4 stars and above for 2025, a reduction from 94% in 2024. A significant driver of these results was contract H5216 decreasing to a 3.5-star rating from a 4.5-star rating in 2024. H5216 contains approximately 45% of Humanas MA membership, including greater than 90% of its employer group waiver plan (Group MA)... More

Humana (HUM) Sinks After Issuing Update on Medicare Advantage Plans for 2025

Humana (NYSE: HUM) shares fell 12% Tuesday after it released details of its Medicare Advantage Plans for 2025.

Humana said it has a total of 793 individual Medicare Advantage plans throughout the country for 2025, with plans offered in 48 states plus Washington, D.C., and Puerto... More